Vaccines are expensive to develop and it can take decades to get them to market. This means promising vaccines often sit in laboratory freezers during major epidemics. That is what happened during the 2014 Ebola outbreak, which killed more than 11,000 people. Today on the show, how that grim equation may be changing.
Music by. Find us:Twitter/Facebook.
Subscribe to our show onApple Podcasts,PocketCastsand.
Copyright 2021 NPR. To see more, visit https://www.npr.org. 9(MDAxODc1ODA5MDEyMjg1MDYxNTFiZTgwZg004))
